baber/WOPTO huggingface dataset:
Patent CA-2842737-A1 (CA)
Inventor: KHORASHADI BEHROOZ
IPC: G06F40/143
Filed: 2012-06-19
Abstract: Methods and devices include a server and at least two web browsers operable on at least two different computing devices. Each browser reports results of processing and rendering of webpages to the server. The server aggregates the data. The server generates metadata from the aggregated browsers. The server transmits the generated metadata to at least one computing device. The computing device renders a webpage using at least a portion of the provided metadata. The metadata may identify portions of JavaScript that can be processed in parallel. The metadata may identify a library portion that does not have to be loaded. The metadata may identify a portion of the webpage that may be rendered first before a second portion of the webpage. Returning metadata to the computing device can assist the computing device in parsing, analyzing or executing the request for the webpage.
Patent CA-2843095-A1 (CA)
Title: Improved rifle sling
Inventor: BELANGER DANIEL
IPC: A45F5/00
Filed: 2014-02-20
Abstract: An improved rifle sling comprising of three buckles on an adjustable belt. An adjustment buckle having two serrated openings, a hooked buckle having two serrated openings and a hook at one end and a sliding buckle angled or bent at the middle with two smooth openings. The adjustment buckle allows the user to adjust the belt to a desired length. The sliding buckle is attached to one end of the belt and slides about the rest of the belt. The sliding buckle hooks onto the hooked buckle that is attached close to the other end of the belt when carrying the rifle close to the body. The sliding buckle is unhooked from hooked buckle adding slack to the belt as it slides across it allowing the rifle to be raised normally when it is to be deployed rapidly into a shooting position. The rifle can be carried across the back or front of a user's body.
Patent CA-2843701-A1 (CA)
Title: Hanging scented bead air freshener
Inventor: WOLF THOMAS H
IPC: A61L9/12
Filed: 2014-02-21
Abstract: This concerns a hangable air freshener that houses aroma-emanating material, such as a plurality of scented beads. The hangable air freshener has a top wall bearing a hook for suspended placement. When at the opened condition, access is provided to a seal which when compromised or removed allows for passage of fragrance from the scented material, through aroma-permeable area, and out of the air freshener and into the surroundings. The hangable air freshener is manufactured in multiple parts, including an upper part with the hook and a lower part within which components for forming the scented beads are positioned, the parts are sealed together with a seam, and expanding volume beads fill the lower part and move into the upper part.
Patent CA-2843869-A1 (CA)
Title: Direction controlled service apparatus
Inventor: BROWN DOUGLAS A
IPC: G05D3/00
Filed: 2014-02-24
Abstract: A direction controlled service apparatus may include a mounting assembly, a housing assembly configured to operably connect to the mounting assembly, the housing assembly being movable with respect to the mounting assembly, and a plurality of actuators connected between the mounting assembly and the housing assembly, each actuator of the plurality of actuators being configured to contract upon a current being applied to the actuator to rotate the housing assembly with respect to the mounting assembly.
Patent CA-2845575-A1 (CA)
Title: Window including integrated display signage
Inventor: HAGEMANN LAWRENCE A
IPC: G09F9/33
Filed: 2012-08-16
Abstract: A display apparatus comprises a transparent panel and a display system for displaying information through a light emitting array that is enclosed within the transparent panel.
Patent CA-2846226-A1 (CA)
Inventor: ELDREDGE STEPHEN
IPC: A61M25/01
Filed: 2012-02-29
Abstract: Systems are disclosed for facilitating intranasal treatment of a patient's sphenopalatine/pterygopalatine recess. Likewise the instant system is effective for addressing acute pain conditions, and is refined enough to be performed by physician's assistants, nurses, and other well-trained practitioners. Apparatus involved includes a sheath hub, a catheter hub, an arresting element, and an engagement element in embodiments. Engagement between the arresting element and the engagement element prevents rotation of the sheath hub with respect to the catheter hub.
Patent CA-2849215-A1 (CA)
Inventor: KEMPER KONRAD
IPC: A01N43/60
Filed: 2005-06-07
Abstract: The invention relates to use of one or more demethylation inhibitor (DMI) fungicides consisting of: a) a triazole: a.1. azaconazole, a.2. bitertanol, a.3.  bromuconazole, a.4. cyproconazole, a.5. difenoconazole, a.6. diniconazole, a.7.  epoxiconazole, a.8.  fenbuconazole, a.10. flusilazole, a.11. flutriafol, a.12. hexaconazole, a.13.  imibenconazole, a.14. ipconazole, a.15. metconazole, a.16. myclobutanil, a.17. paclobutrazol, a.18.  penconazole, a.19. propiconazole, a.21. simeconazole, a.22. tebuconazole, a.23. tetraconazole, a.24. triadimenol, a.25. triticonazole; b) a pyrimidine: b.1. fenarimol, b.2.  nuarimol; c) a pyridine: c.1. pyrifenox; or d) an imidazole: d.1. imazalil, d.2. oxpoconazole fumarate, d.3.  peforazoate, d.4. prochloraz, d.5. triflumizole, as seed dressing for soya beans against soya bean rust.
Patent CA-2850408-A1 (CA)
Inventor: GRECO GIORGIO
IPC: F01D25/00
Filed: 2012-09-27
Abstract: A system and method is provided determining a degree of fouling formation in a compressor, e.g., in an ethylene production unit or other application. Data associated with the operation of the compressor is collected (100). Based on the collected data, polytropic efficiency of the compressor is calculated (102). The estimated polytropic efficiency is normalized (104) to render the estimate more indicative of the degree of fouling (106).
Patent CA-2850836-A1 (CA)
Title: Methods of using scd1 antagonists
Inventor: ASHKENAZI AVI
IPC: A61K39/00
Filed: 2012-10-12
Abstract: Provided herein are therapies for the treatment of pathological conditions, such as cancer, and method of using SCD1 antagonists.
Patent CA-2852582-A1 (CA)
Title: Internally cooled seal runner
Inventor: BLAIS DANIEL
IPC: F02C7/12
Filed: 2014-05-23
Abstract: A contact seal assembly for a shaft of a gas turbine engine includes a seal runner adapted to be connected to the shaft and rotatable relative to a carbon ring. The seal runner includes concentric inner and outer annular portions radially spaced apart to define at least one internal fluid passage between the inner and outer annular portions of the seal runner.
Patent CA-2852869-A1 (CA)
Inventor: ANDRE JEAN-LUC
IPC: B61B13/04
Filed: 2012-10-24
Abstract: Le système de contrôle dynamique (1 ) du roulage sur au moins un rail de guidage pour un ensemble de guidage (2) d'un véhicule le long d'au moins un rail de guidage (3) formé d'au moins un galet (9) ou d'au moins une paire (1 1, 14) de galets de guidage (9) roulant le long de ce rail de guidage (3) est caractérisé en ce qu'il comporte un capteur vibratoire (5) situé près du au moins un galet (9) ou de l'au moins une paire (1 1, 14) de galets de guidage (9) et un capteur de proximité (7), et en ce que les signaux issus de ces capteurs (5, 7) ou des circuits dans lesquels ils sont placés sont analysés en permanence pour déterminer un début de déguidage, un déguidage ou une limite d'usure ou une détérioration du ou des galets (9) ou du bandage (24) de ceux-ci. Cette invention intéresse les constructeurs de véhicules guidés le long d'au moins un rail.
Patent CA-2857109-A1 (CA)
Title: Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agent
Inventor: KHAIRATKAR-JOSHI NEELIMA
IPC: A61K31/4985
Filed: 2012-12-05
Abstract: The present invention relates to a pharmaceutical composition comprising a transient receptor potential ankyrin-1 receptor ("TRPA1") antagonist and an anticholinergic agent. Particularly, the present invention provides a pharmaceutical composition comprising a TRPA1 antagonist having IC50 for inhibiting human TRPA1 receptor activity of less than 1 micromolar and an anticholinergic agent; a process for preparing such composition; and its use in treating a respiratory disorder in a subject.
Patent CA-2857836-A1 (CA)
Inventor: ISABELLE MICHAEL ALLAN
IPC: F41B11/52
Filed: 2014-07-25
Abstract: An assembly for rapid loading and feeding of paintballs in a paintball marker comprises a receiver mountable on the marker, having an opening to receive and secure a magazine carrying paintballs. An ejection mechanism to clear a magazine from the opening may also be provided. The magazine comprises an outer shell that interacts with the receiver to secure the magazine, and holds an arming mechanism that is manipulated by twisting or pulling to selectively cover apertures in the outer shell to secure the paintballs within the magazine, or uncover the apertures to release the paintballs.
Patent CA-2859019-A1 (CA)
Title: Fluorescent measurement in a disposable microfluidic device, and method thereof
Inventor: LEWIS WILLIAM
IPC: C12Q1/68
Filed: 2012-12-06
Abstract: A device including a shallow chamber for analyzing a target analyte in a body fluid using the signal generated by fluorescent detector molecules specific for the target analyte and attenuating the signal emitted by fluorescent detector molecules non-specifically bound to the surfaces of the chamber by a signal attenuating dye; and method thereof. fluorescent measurement in a disposable microfluidic device, and method thereof
Patent CA-2859708-A1 (CA)
Inventor: GRUBER CHRISTIAN WERNER
IPC: A61K38/56
Filed: 2012-12-21
Abstract: The present invention relates to a pharmaceutical composition comprising a cyclotide for use in immune suppression as well as to a method for immune suppression comprising the step of administering an effective amount of a pharmaceutical composition comprising such a cyclotide to a subject in need thereof. The present invention also relates to a pharmaceutical composition comprising a cyclotide for use in treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation. Likewise, the present invention also relates to a method for treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation. The present invention further relates to a method of screening for and/or selecting an immunosuppressive cyclotide or a mutation which results in a mutated cyclotide having an induced or enhanced immunosupressive activity. The present invention further relates to a method of producing an immunosuppressive cyclotide or an immunosuppressive pharmaceutical composition. The present invention further relates to a mutated cyclotide having immunosuppressive activity and a pharmaceutical composition comprising the same.
Patent CA-2862567-A1 (CA)
Inventor: NAKO HIDENORI
IPC: B23K9/173
Filed: 2013-02-25
Abstract: The present invention is a weld metal formed by gas shielded arc welding using a flux cored wire, the welded metal having a predetermined chemical composition, residual austenite particles being present in an amount of at least 2500 particles/mm2, and the volume fraction of residual austenite particles being at least 4.0%.
Patent CA-2865523-A1 (CA)
Inventor: LO YUK MING DENNIS
IPC: C12Q1/68
Filed: 2013-03-08
Abstract: A fractional concentration of clinically-relevant DNA in a mixture of DNA from a biological sample is determined based on amounts of DNA fragments at multiple sizes. For example, the fractional concentration of fetal DNA in maternal plasma or tumor DNA in a patient's plasma can be determined. The size of DNA fragments in a sample is shown to be correlated with a proportion of fetal DNA and a proportion of tumor DNA, respectively. Calibration data points (e.g., as a calibration function) indicate a correspondence between values of a size parameter and the fractional concentration of the clinically-relevant DNA. For a given sample, a first value of a size parameter can be determined from the sizes of DNA fragments in a sample. A comparison of the first value to the calibration data points can provide the estimate of the fractional concentration of the clinically-relevant DNA.
Patent CA-2869832-A1 (CA)
Inventor: FREGONESE ALEXANDRA
IPC: A23L33/00
Filed: 2013-04-10
Abstract: La présente invention concerne l'utilisation d'un complexe beepollen/argile à titre de support pour l'administration de probiotiques, ainsi que les compositions comprenant un ou plusieurs probiotiques et ledit complexe beepollen/argile.
Patent CA-2870339-A1 (CA)
Title: Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
Inventor: FURET PASCAL
IPC: C07D233/38
Filed: 2013-05-09
Abstract: The present invention relates to compounds of formula I: in which Y, Y1, Y 4, Y5, Y 6, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.
Patent CA-2870533-A1 (CA)
Inventor: YOUBI-IDRISSI MOHAMMED
IPC: F25D3/10
Filed: 2013-02-22
Abstract: L'invention concerne un procédé de transport de produits thermosensibles en camion réfrigéré, du type à injection indirecte, où l'on régule la température Tint interne à la chambre de stockage en faisant varier le pincement de l'échangeur (Pincement = Tint - TSOrtie fluide ) en fonction de la position de la température interne Tint par rapport à une température de consigne.
Patent CA-2873435-A1 (CA)
Inventor: SIVIK MARK ROBERT
IPC: C11D3/37
Filed: 2013-05-21
Abstract: The present invention relates to fabric treatment compositions containing multi-phase systems, polymers for use in multi-phase systems as well as products comprising such systems and methods of making and using same. Such treatment compositions may be used for example as laundry additives, and/or through the rinse to provide benefits including enhanced softening, color benefits, and wrinkle reduction.
Patent CA-2873591-A1 (CA)
Inventor: WOLFE JONATHAN
IPC: G06Q30/02
Filed: 2013-05-14
Abstract: The present invention provides a social networking platform offering various services, such as, facilitating aggregation and management of a user's interaction on one or more social networking platforms, offering enhanced control over the level of privacy associated with the flow of user data, offering tools to customize the user's exposure to advertisement-related content on the social networking platform(s), integrating features to control aspects of how data/content is presented to and visualized by the user, empowering the user to multicast direct messages to other users without the other users having to meet certain constraints, empowering the user to create and/or join a group based on messaging threads, and the like. One or more of these enhanced services/features are associated with a powerful framework of authentication/permission model for access control.
Patent CA-2873906-A1 (CA)
Title: Method for isolation of soluble polypeptides
Inventor: TANHA JAMSHID
IPC: C12N15/13
Filed: 2006-03-24
Abstract: Polypeptides with desirable biophysical properties such as solubility, stability, high expression, monomericity, binding specificity or non-aggregation, including monomeric human VHs and VLs, are identified using a high throughput method for screening polypeptides, comprising the steps of obtaining a phage display library, allowing infection of a bacterial lawn by the library phage, and identifying phage which form larger than average plaques on the bacterial lawn. Sequences of monomeric human VHs and VLs are identified, which may be useful for immunotherapy or as diagnostic agents. Multimer complexes of human VHs and VLs are also identified. The VHs and VLs identified may be used to create further libraries for identifying additional polypeptides. Further, the VHs and VLs may be subjected to DNA shuffling to select for improved biophysical properties.
Patent CA-2874746-A1 (CA)
Inventor: AGRAWAL PRATIK
IPC: G06F19/00
Filed: 2013-06-06
Abstract: A method of managing use of an insulin infusion device are provided. The method receives glucose data for a user of the infusion device, wherein the glucose data indicates blood glucose levels of the user for a period of time during which the insulin infusion device is regulating delivery of insulin to the user. The received glucose data is received to detect certain event occurrences, which may be indicative of a correctable basal rate setting of the insulin infusion device and/or indicative of potential maladjustment of a user-specific setting of a bolus calculator setting of the insulin infusion device. The method outputs a recommendation to adjust the basal rate setting and/or the bolus calculator setting as needed to address the detected event occurrences.
Patent CA-2876526-A1 (CA)
Inventor: CROSS DAVID MURRAY
IPC: A47J31/06
Filed: 2013-07-02
Abstract: A method of preparing a tea beverage in a brewing device is provided, the device comprising an infusion chamber with a bottom rim which defines an opening; a capsule holder for receiving a capsule, the capsule holder comprising a filter and an openable and closable passage; the method comprising: inserting a capsule into the capsule holder; connecting the capsule holder to the infusion chamber; introducing liquid into the capsule so that the liquid and tea material mix and flow into the infusion chamber and brew the beverage; and then opening the passage to allow the beverage to flow from the infusion chamber through the filter and out through the passage. A capsule containing tea material for use in the method is also provided, the capsule comprising a body part, which is a single, impermeable piece which defines a cavity with a volume of from 10 to 24cm3.
Patent CA-2876904-A1 (CA)
Title: Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
Inventor: WEST JAMES WILLIAM
IPC: A61P35/00
Filed: 2013-06-21
Abstract: This invention relates generally to the generation of antibodies, e.g., monoclonal antibodies including fully human monoclonal antibodies, that recognize Jagged 1 and/or Jagged 2, to antibodies, e.g., monoclonal antibodies including fully human antibodies that recognize Jagged 1 and/or Jagged 2, and nucleic acid molecules that encode antibodies, e.g., nucleic acid molecules that encode monoclonal antibodies including fully human cross-reactive antibodies that recognize both Jagged 1 and Jagged 2, and to methods of making the anti- Jagged antibodies and methods of using the anti- Jagged antibodies as therapeutics, prophylactics, and diagnostics. The invention also relates generally to activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically bind to Jagged 1 and Jagged 2, and to methods of making and using these activatable anti- Jagged antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Patent CA-2878165-A1 (CA)
Title: Olefin-maleic anhydride copolymer compositions and uses thereof
Inventor: ADUR ASHOK M
IPC: C08L77/06
Filed: 2013-07-03
Abstract: Described herein are concentrate compositions (e.g. master batches) comprising olefin-maleic anhydride copolymers and other additives dispersed in various carrier resins and methods for their preparation and use. A preferred embodiment described herein is a process for producing an olefin-maleic anhydride copolymer master batch with alternating 1 :1 ethylene maleic anhydride copolymers (EMAH). In a further embodiment, the process includes an extrusion compounding step.
Patent CA-2883105-A1 (CA)
Inventor: HERLING JAN
IPC: G06T5/00
Filed: 2012-09-05
Abstract: The present invention provides a method and an image processing system for removing a visual object from an image. A visual object to be removed from within an image is selected, for which a mask is determined. Pixels outside the mask intended to be used for replacing pixels inside the mask are selected based on a similarity measure, which comprises an appearance similarity measure that represents visual similarity between a previously selected pixel for replacing the pixel to be replaced and the pixel to be selected. The similarity measure further comprises a geometry similarity measure, which represents proximity of the pixel to be selected to the pixel among the pixels outside the mask that was previously used for replacing the pixel adjacent to the pixel to be replaced. The pixels inside the mask are then replaced by copying properties of the selected pixels to the respective pixels to be replaced.
Patent CA-2883593-A1 (CA)
Title: Mechanical actuator
Inventor: SJOBECK ROGER
IPC: F15B15/14
Filed: 2012-11-15
Abstract: A mechanical actuator configured to prevent the ingress of contaminant particulates from propagating under the cylinder head to destroy the fluid tight seal at the actuator chamber. An annular collar is tethered to an outer end region of the cylinder barrel and comprises at least one scraper and seal to provide a preliminary cleaning of the piston rod.
Patent CA-2884089-A1 (CA)
Inventor: CHAPPLE IAIN
IPC: G01N33/68
Filed: 2013-09-10
Abstract: Methods for diagnosing the status of periodontitis disease includes selecting a set of protein biomarkers including one or more biomarkers which have been shown to vary in abundance at particular stages of periodontitis. The set of protein biomarkers may be identified and quantified in expression in an acquired gingival crevicular fluid (GCF) or saliva oral fluid sample in order to distinguish between different states of periodontitis. Methods of diagnosing the status of periodontitis oral disease at varying levels of severity, e.g. gingivitis, mild periodontitis, or severe periodontitis, may include selecting a set of protein biomarkers which are capable distinguishing between different stages of periodontitis.
Patent CA-2884369-A1 (CA)
Inventor: YOSHIOKA NOBUAKI
IPC: H01M50/503
Filed: 2013-09-18
Abstract: Provided is a connecting structure (1) that uses a crimp terminal (4) to connect a bus bar (2) and an electrical wire (3). The crimp terminal (4) comprises a bus bar-connecting section (41) that is crimped to the bus bar (2) and an electrical wire-connecting section (42) that is crimped to the end of the electrical wire (3). At least one of the bus bar-connecting section (41) and the end of the electrical wire (3) is provided with an oxide film breaking means (5) that breaks the oxide film of the bus bar (2) or of the core wire (31) of the end of the electrical wire (3).
Patent CA-2884491-A1 (CA)
Inventor: TAHRI ABDELLAH
IPC: C07D491/20
Filed: 2013-10-15
Abstract: Inhibitors of RSV replication of formula RI including stereochemically isomeric forms, and salts or solvates thereof, wherein R22, W, Q, V, Z p,s,and Het have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other RSV inhibitors, in RSV therapy.
Patent CA-2884604-A1 (CA)
Title: Material reducing apparatus including an automatically positioned thrown object deflector
Inventor: HARTHOORN DUANE
IPC: A01D34/52
Filed: 2015-03-06
Abstract: The present disclosure relates to a material reducing apparatus adapted to be coupled to a vehicle by a pivot arm or other structure. The material reducing apparatus includes a reducing head with rotary reducing component. The reducing head can be titled about a tilt axis relative to the vehicle and can be raised and lowered relative to a vehicle. The reducing head has a thrown object deflector that automatically moves relative to the rotary reducing component when the reducing head is tilted relative to the vehicle.